I assume these posts are for people that trade in
Post# of 148175
I look at it as: we have a company worth perhaps 10 billion or more - with a current market cap of 230 mm - and science marching steadily on. Unless Clay Trader, Adam Firestein (or whoever) is going to invent a new compound that replaces what Leronlimab does and out-competes us, I’m not terribly worried about my investment.
What makes me feel even better is that I’ve been on Wall Street for 20 years and have never heard of these people. Ray Dalio, Jeff Gundlach, yes. Clay Trader, Adam Firestein - who? Bush league.